← Browse by Condition
Medical Condition

acute coronary syndrome

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for acute coronary syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — acute coronary syndrome Clinical Trials

How many clinical trials are currently recruiting for acute coronary syndrome?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for acute coronary syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for acute coronary syndrome?
acute coronary syndrome research spans Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a acute coronary syndrome clinical trial?
Eligibility criteria for acute coronary syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
2
Top Sponsors
Su Guohai 1 trial
Centre Hospitalier Universitaire de Saint Etienne 1 trial
Hospital de Clinicas José de San Martín 1 trial
St. Antonius Hospital 1 trial
Biosensors Europe SA 1 trial

Recruiting Clinical Trials

NCT05719545
Recruiting
A Cohort of Patients Undergoing Percutaneous Coronary Intervention
Enrollment
10,000 pts
Location
China
Sponsor
Su Guohai
View Trial →
NCT06107452
Recruiting
Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability
Enrollment
110 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06513611
Recruiting
Cellular Immunity, Neuroendocrine, and Inflammatory Factors for Clinical Prognosis in Acute Coronary Syndrome
Enrollment
150 pts
Location
Argentina
Sponsor
Hospital de Clinicas José de S...
View Trial →
NCT04436978 Phase 4
Recruiting
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Enrollment
2,000 pts
Location
Belgium, Netherlands
Sponsor
St. Antonius Hospital
View Trial →
NCT06657326
Recruiting
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
Enrollment
444 pts
Location
Malaysia
Sponsor
Biosensors Europe SA
View Trial →
NCT06215989
Recruiting
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
Enrollment
6,574 pts
Location
China
Sponsor
Beijing Anzhen Hospital
View Trial →
NCT04218344
Recruiting
The Harefield Acute Myocardial Infarction Cohort
Enrollment
2,000 pts
Location
United Kingdom
Sponsor
Royal Brompton & Harefield NHS...
View Trial →
NCT06255678
Recruiting
Angio-based Final Functional Effect of PCI
Enrollment
2,005 pts
Location
Poland
Sponsor
Medical University of Warsaw
View Trial →
NCT04937699 Phase 4
Recruiting
Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention
Enrollment
2,690 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →

Related Conditions

unstable angina (3) percutaneous coronary intervention (2) myocardial infarction (2) coronary artery disease (2) stress hyperglycemia (1) cortisol hypersecretion (1) inflammatory response (1) coagulation (1) atrial fibrillation (1) atrial flutter (1) stemi st elevation myocardial infarction (1) nstemi non st segment elevation mi (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology